mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential

about

mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential

Item

http://www.wikidata.org/entity/Q59130211

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

mTORC1 is a key mediator of RO ...... sis with therapeutic potential

@en

mTORC1 is a key mediator of RO ...... sis with therapeutic potential

@nl

type

Item

label

mTORC1 is a key mediator of RO ...... sis with therapeutic potential

@en

mTORC1 is a key mediator of RO ...... sis with therapeutic potential

@nl

prefLabel

mTORC1 is a key mediator of RO ...... sis with therapeutic potential

@en

mTORC1 is a key mediator of RO ...... sis with therapeutic potential

@nl

P1476

mTORC1 is a key mediator of RO ...... sis with therapeutic potential

@en

P2093

Alana L Welm

http://www.w3.org/2001/XMLSchema#string

Ling Zhao

http://www.w3.org/2001/XMLSchema#string

Najme Faham

http://www.w3.org/2001/XMLSchema#string

P2860

The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity

Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily

Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress

P2888

s41523-018-0091-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41523-018-0091-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30456298

http://www.w3.org/2001/XMLSchema#string

P932

6226524

http://www.w3.org/2001/XMLSchema#string